- Home
- PGNY vs SRPT Comparison
PGNY vs SRPT Comparison
Compare PGNY & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PGNY
- SRPT
- Stock Information
- Founded
- PGNY 2008
- SRPT 1980
- Country
- PGNY United States
- SRPT United States
- Employees
- PGNY N/A
- SRPT N/A
- Industry
- PGNY Misc Health and Biotechnology Services
- SRPT Biotechnology: Pharmaceutical Preparations
- Sector
- PGNY Health Care
- SRPT Health Care
- Exchange
- PGNY Nasdaq
- SRPT Nasdaq
- Market Cap
- PGNY 2.0B
- SRPT 2.0B
- IPO Year
- PGNY 2019
- SRPT 1997
- Fundamental
- Price
- PGNY $21.63
- SRPT $17.16
- Analyst Decision
- PGNY Buy
- SRPT Hold
- Analyst Count
- PGNY 8
- SRPT 31
- Target Price
- PGNY $26.14
- SRPT $40.61
- AVG Volume (30 Days)
- PGNY 903.7K
- SRPT 7.8M
- Earning Date
- PGNY 11-11-2025
- SRPT 11-05-2025
- Dividend Yield
- PGNY N/A
- SRPT N/A
- EPS Growth
- PGNY N/A
- SRPT N/A
- EPS
- PGNY 0.58
- SRPT N/A
- Revenue
- PGNY $1,241,968,000.00
- SRPT $2,481,531,000.00
- Revenue This Year
- PGNY $10.00
- SRPT $10.78
- Revenue Next Year
- PGNY $9.42
- SRPT N/A
- P/E Ratio
- PGNY $37.36
- SRPT N/A
- Revenue Growth
- PGNY 9.62
- SRPT 64.89
- 52 Week Low
- PGNY $13.39
- SRPT $10.42
- 52 Week High
- PGNY $26.76
- SRPT $138.81
- Technical
- Relative Strength Index (RSI)
- PGNY 39.40
- SRPT 43.53
- Support Level
- PGNY $22.43
- SRPT $17.05
- Resistance Level
- PGNY $23.20
- SRPT $18.84
- Average True Range (ATR)
- PGNY 0.58
- SRPT 0.94
- MACD
- PGNY -0.19
- SRPT -0.10
- Stochastic Oscillator
- PGNY 5.86
- SRPT 11.38
About PGNY Progyny Inc.
Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.